CEL-SCI
CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.
CEL-SCI
Industry:
Biotechnology Health Care Medical
Founded:
1983-01-01
Address:
Vienna, Virginia, United States
Country:
United States
Website Url:
http://www.cel-sci.com
Total Employee:
11+
Status:
Active
Contact:
7035069471
Total Funding:
56.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
AltruBio
AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Agilvax
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases.
Antria
Antria is a clinical research firm developing regenerative medicine and cellular therapies for the treatment of diverse diseases.
Arbovax
Arbovax engages in the preclinical and clinical development of vaccine products for the prophylactic treatment of arthropod-borne diseases.
Arno Therapeutics
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
AVM Biotechnology
AVM Biotechnology is a clinical stage company.
AxoGen
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
Benvenue Medical
Benvenue Medical is a biotech company developing innovative and minimally invasive surgical solutions for the treatment of spinal disorders.
Bioniz Therapeutics
Bioniz is a biotechnology company focuses on discovering small peptides and molecules for the treatment of autoimmune diseases and cancer.
Biothera
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
BONESUPPORT
BONESUPPORT is a medical technology company that develops injectable osteoconductive biomaterials for the treatment of fragility fractures.
CAPNIA
CAPNIA employs its proprietary medical gas delivery system to develop therapeutic products for chronic diseases.
Companion Medical
Companion Medical develops a technology designed for those living with Type 1 or Type 2 insulin-dependent diabetes.
Cue Biopharma
Cue Biopharma has developed a highly productive platform for the treatment of cancer and autoimmune disease.
CVRx
CVRx is a medical device company developing implantable technology for the treatment of high blood pressure.
Decoy Biosystems
Decoy Biosystems is a biotechnology company developing novel, multi-targeted products designed to eliminate viral and bacterial infections.
DyCare
DyCare is a biotech company that specializes in development of innovative solutions for the control and clinical assessment of diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Eiger BioPharmaceuticals
Eiger is a biopharmaceutical company that develops new antiviral agents against novel targets in the treatment of hepatitis.
Fibrocell Science
Fibrocell Science is an autologous cell therapy company developing products for aesthetic, medical and scientific applications.
First Light Diagnostics
First Light Diagnostics develops innovative medical diagnostic products for the detection of Healthcare Associated Infections.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Gismo Therapeutics
Gismo Therapeutics, a biotechnology startup, develops small-molecule therapeutics for the treatment of Alzheimer’s and Parkinson’s diseases.
Biostage
Biostage is a biotechnology company developing next-generation esophageal implants for patients battling life-threatening conditions.
Heat Biologics
Heat Biologics is a biotechnology company focused on the field of cancer immunotherapy.
Igenica
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Innate Pharma
Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Kite Pharma
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
LTZ Therapeutics
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
MacroGenics
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.
MiNDERA Corporation
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.
Abliva AB
Abliva develops medicines for the treatment of primary mitochondrial diseases.
Nuron Biotech
Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.
Opsonix
Opsonix is a developer of a pathogen-extracting therapy designed to transform the treatment of bloodstream infections and sepsis.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Puma Biotechnology
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Retrotope
Retrotope is a developer of a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases.
RetroVirox
RetroVirox is a privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases
Senhwa Biosciences
Senhwa is a drug development company creating innovative therapies for cancer and related diseases.
Sojournix
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Theron Pharmaceuticals
Theron Pharmaceuticals is a biotechnology company that develops therapeutic products for the treatment of chronic respiratory diseases.
Vaccinogen
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.
Vascugen
Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular diseases.
Vedanta Biosciences
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Versartis
Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Maximilian de Clara President & Director @ CEL-SCI
President & Director
Geert R. Kersten CEO, Treasurer & Director @ CEL-SCI
CEO, Treasurer & Director
Eyal Talor CSO @ CEL-SCI
CSO
Founder
Stock Details
Investors List
Aegis Capital Corporation
Aegis Capital Corporation investment in Post-IPO Equity - CEL-SCI
Rockmore Capital
Rockmore Capital investment in Post-IPO Equity - CEL-SCI
ArmaVir Partners
ArmaVir Partners investment in Post-IPO Equity - CEL-SCI
Paramount BioCapital Asset Management
Paramount BioCapital Asset Management investment in Post-IPO Equity - CEL-SCI
Iroquois Capital
Iroquois Capital investment in Post-IPO Equity - CEL-SCI
Whalehaven Capital Fund
Whalehaven Capital Fund investment in Post-IPO Equity - CEL-SCI
Alpha Capital
Alpha Capital investment in Post-IPO Equity - CEL-SCI
Midsummer Capital
Midsummer Capital investment in Post-IPO Equity - CEL-SCI
Official Site Inspections
http://www.cel-sci.com
- Host name: vps100260.inmotionhosting.com
- IP address: 173.231.248.61
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "CEL-SCI"
About Us - Cel Sci
History CEL-SCI’s story is one of vision, persistence, and survival in the face of overwhelming odds. Despite downturns in the biotech sector, many times lack of funding, a lengthy clinical …See details»
Cel-Sci Corporation - Wikipedia
Cel-Sci has also worked on LEAPS (Ligand Epitope Antigen Presentation System), a system of therapeutic vaccines for rheumatoid arthritis. The company is also testing HGP-30 to determine if it is an effective treatment against the AIDS virus. In 1996, The Washington Post reported that the company was conducting its testing without the backing of the FDA because they couldn't agree on study details with said regulatory organiz…See details»
History - Cel Sci
CEL-SCI hired an experienced Clinical Research Organization to run this global study. However, in April 2013 CEL-SCI had to transfer the management of its Phase 3 trial for Multikine in the …See details»
CEL-SCI - Crunchbase Company Profile & Funding
CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. …See details»
Org Chart Cel-sci - The Official Board
The organizational chart of Cel-sci displays its 10 main executives including Geert Kersten, William Jones and Daniel ZimmermanSee details»
CEL-SCI Corporation Company Profile - Dun & Bradstreet
Company Description: CEL-SCI hopes to make L.E.A.P.S. and bounds in preventing and treating deadly diseases. Its L.E.A.P.S. (Ligand Epitope Antigen Presentation System) technology …See details»
CEL-SCI Corp. - AnnualReports.com
CEL-SCI Corporation, a biotechnology company, is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. Visit website. REPORT RATINGS. 4.8 / 5.0 (143) CEL …See details»
CEL-SCI - Org Chart, Teams, Culture & Jobs - The Org
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. Industries. Biotechnology, Health Care. Headquarters. …See details»
CEL-SCI Corp. - Drug pipelines, Patents, Clinical trials - Synapse
CEL-SCI selected Ergomed, a clinical research organization (CRO) with a strong track record of fast enrollment and high-quality study delivery, as the CRO for its relatively small registration …See details»
Management Team - Cel Sci
She joined CEL-SCI in 1992 and was CEL-SCI's Senior Vice President of Operations from March 1994 to October 2024. Between December 1992 and March 1994, Ms. Prichep was CEL-SCI's Director of Operations. Ms. Prichep …See details»
CEL-SCI Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 CEL-SCI is a biotechnology company. It is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. …See details»
CEL-SCI Reports Fiscal 2024 Results: Set to Commence …
4 days ago VIENNA, Va., January 14, 2025--CEL-SCI reports fiscal 2024 results: set to commence confirmatory study that could bring new standard of care to head & neck cancer.See details»
An Overview of CEL-SCI Corporation (CVM) - dcf.fm
[relinking] Home Overview Mission Vision Values An Overview of CEL-SCI Corporation (CVM)General Summary of CEL-SCI Corporation Founded in 1983, CEL-SCI Corporation …See details»
CEL-SCI Reports Fiscal 2024 Results: Set to Commence ... - BioSpace
3 days ago CEL-SCI selected Ergomed, a clinical research organization (CRO) with a strong track record of fast enrollment and high-quality study delivery, as the CRO for its relatively …See details»
Mission, Vision & Core Values of CEL-SCI
Dec 17, 2024 CEL-SCI, a groundbreaking biotechnology company, is driven by a clear mission, vision, and core values that guide every aspect of its operations. Our mission is to leverage …See details»
New Investor Information - Cel Sci
Oct 23, 2023 Communication with the Board of Directors · Holders of CEL-SCI's common stock can send written communications to CEL-SCI's entire Board of Directors, or to one or more …See details»
CEL-SCI - Products, Competitors, Financials, Employees, …
CEL-SCI (NYSE:CVM) Cut to “Sell” at StockNews.com Posted by MarketBeat News on Nov 20th, 2024 CEL-SCI Stock Up 13.4 % Shares of CEL-SCI stock opened at $0.64 on Wednesday. …See details»
Cel-Sci Corporation - Cruelty Free Investing
CEL-SCI has operations in Vienna, Virginia and Baltimore, Maryland. CEL-SCI’s other products, which are currently in pre-clinical stage, have shown protection against a number of diseases …See details»
CEL-SCI Reports Fiscal 2024 Results: Set to Commence ... - Nasdaq
Sep 30, 2024 CEL-SCI selected Ergomed, a clinical research organization (CRO) with a strong track record of fast enrollment and high-quality study delivery, as the CRO for its relatively …See details»
CEL-SCI Careers
CEL-SCI will recruit, hire, train, and promote into all job titles the most qualified individuals, without regard to race, color, creed, protected veteran status or disability, gender, religion, …See details»